Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis B With Hepatic Fibrosis”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Post-approval studies (Phase 4)UnknownNCT04584242
What this trial is testing

Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Who this might be right for
Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
Yonsei University 40
Not applicableStudy completedNCT05560503
What this trial is testing

A Nomogram for Evaluating Significant Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Liver Fibrosis
Xiangya Hospital of Central South University 259
Large-scale testing (Phase 3)Study completedNCT07343778
What this trial is testing

A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis

Who this might be right for
Chronic Hepatitis B With Hepatic Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 337
Testing effectiveness (Phase 2)Ended earlyNCT01217632
What this trial is testing

FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Who this might be right for
Liver Fibrosis Due to Chronic Hepatitis B Infection
Kyntra Bio 114
Post-approval studies (Phase 4)UnknownNCT05473806
What this trial is testing

Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

Who this might be right for
Hepatitis B, ChronicFibrosis, LiverDiabetes Mellitus, Type 2
Seung Up Kim 28
Not applicableStudy completedNCT04759521
What this trial is testing

Evaluation of Liver Fibrosis With 2D-Shear Wave Elastography

Who this might be right for
Chronic Hepatitis BSonoelastographyFibrosis, Liver
Seyhmus Kavak 253
Early research (Phase 1)Study completedNCT04123769
What this trial is testing

Study on PK of Hydronidone in Patients and Special Population

Who this might be right for
Hepatitis b & Liver Dysfunction
Beijing Continent Pharmaceutical Co, Ltd. 8
Not applicableUnknownNCT02889094
What this trial is testing

French HIV-HBV Cohort

Who this might be right for
Hepatitis BHIVLiver Cirrhosis+1 more
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 152
Early research (Phase 1)Study completedNCT07295873
What this trial is testing

Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide

Who this might be right for
Chronic Hepatitis B Liver FibrosisDDI (Drug-Drug Interaction)
Beijing Continent Pharmaceutical Co, Ltd. 64
Not applicableStudy completedNCT01908660
What this trial is testing

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Who this might be right for
Human Immunodeficiency VirusHepatitis B, ChronicHepatitis C, Chronic
Valme University Hospital 192
Not applicableStudy completedNCT02044523
What this trial is testing

Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound

Who this might be right for
Hepatitis CHepatitis BNonalcoholic Fatty Liver Disease (NAFLD)+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 108
Not applicableStudy completedNCT01537965
What this trial is testing

Evaluation of Innovative Ultrasonic Techniques for Non-invasive Diagnosis of Liver Fibrosis in Patients With Chronic Viral Hepatitis B or C

Who this might be right for
Liver Fibrosis
University Hospital, Grenoble 96
Not applicableLooking for participantsNCT06874127
What this trial is testing

Non-Invasive Model for Fibrosis Regression in HBV Patients

Who this might be right for
Chronic Hepatitis B Virus (HBV) InfectionLiver Fibrosis
Beijing Friendship Hospital 1,100
Post-approval studies (Phase 4)Active Not RecruitingNCT05147090
What this trial is testing

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis bNAFLDCirrhosis+3 more
The University of Hong Kong 106
Not applicableStudy completedNCT02031913
What this trial is testing

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

Who this might be right for
Chronic Hepatitis BHepatic FibrosisFatty Liver
Seoul National University Boramae Hospital 500
Not applicableStudy completedNCT05871749
What this trial is testing

Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B

Who this might be right for
Hepatic SteatosisHepatic FibrosisChronic Hepatitis b
So Yeon Kim 120
Testing effectiveness (Phase 2)Study completedNCT07417553
What this trial is testing

Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

Who this might be right for
Chronic Hepatitis B-related Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 67
Post-approval studies (Phase 4)Ended earlyNCT01341106
What this trial is testing

Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection

Who this might be right for
Hepatitis B, ChronicLiver Fibrosis
RWTH Aachen University 7
Testing effectiveness (Phase 2)WithdrawnNCT02289300
What this trial is testing

Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

Who this might be right for
Liver FibrosisHEPATITIS B CHRONICHepatocellular Carcinoma
A2 Healthcare Taiwan Corporation
Testing effectiveness (Phase 2)Study completedNCT00956098
What this trial is testing

Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis

Who this might be right for
Liver FibrosisLiver Cirrhosis
HK inno.N Corporation 81
Next Page